Kejin Zhou

Founder and CEO Reinvigoron TheraTech Inc.

Kejin Zhou is a serial biotechnology platform developer, propelled by a steadfast commitment to realizing a cancer-free future. With demonstrated proficiency in Organic Chemistry, Polymer Physics, Nanotechnology, Drug Delivery, Biology, Cancer Biology, Immunology, Pharmacology, and Pharmaceutical Science, Kejin has played a pivotal role in the development of two platform technologies licensed to VC-backed biotech companies—OncoNano Medicine and Recode Therapeutics. The fight against cancer holds deeply personal significance for Kejin. Having experienced the anguish of witnessing his young niece's suffering and eventual loss to cancer, he harbors an unwavering determination to spare others from similar pain. Motivated by this trauma, Kejin founded Reinvigoron TheraTech, where the primary mission is to eradicate cancer. At Reinvigoron, the focus lies on inventing safe, life-saving, and scalable therapies, particularly targeting patients battling advanced metastatic solid cancer.

Doctor of Philosophy (Ph.D.), Polymer Chemistry and Physics 2003-2009
image-15 Team Leadership
image-9 Leadership
image-1 Strategic Planning

Register to for Kejin Zhou episodes, events, and more.

Already have an account?